Published online Feb 26, 2017. doi: 10.4330/wjc.v9.i2.109
Peer-review started: October 19, 2016
First decision: November 30, 2016
Revised: December 2, 2016
Accepted: January 2, 2017
Article in press: January 3, 2017
Published online: February 26, 2017
Processing time: 130 Days and 13.5 Hours
Core tip: Cardiovascular magnetic resonance (CMR) imaging uniquely characterizes myocardial and microvascular injury in acute myocardial infarction (AMI). Contrast-enhanced CMR offers robust, validated and reproducible surrogate markers, providing an accurate representation of pathophysiology, assessment of myocardial function and injury, and predictive value for medium to long-term LV function, remodelling and prognosis following primary percutaneous coronary intervention for STEMI. These qualities significantly increase the statistical power of studies using CMR endpoints and has resulted in an exponential increase in AMI studies utilizing CMR based endpoints. An understanding of the role of CMR in the assessment of outcomes in AMI is of key importance not only to interventional and imaging cardiologists, but to the cardiology community as a whole.
